Immunocompromised: Clinical Trials

1 trial for Immunocompromised, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Immunocompromised: new trials by email Literature Review of Immunocompromised trials Research Report on Immunocompromised

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults
casirivimab+imdevimab, Placebo - Immunocompromised
Phase 3TerminatedRegeneron Pharmaceuticals662021-10-252025-10-20

Narrower conditions

COVID-19 (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

casirivimab (1)  ·  casirivimab and imdevimab drug combination (1)  ·  imdevimab (1)

Sponsors

Regeneron Pharmaceuticals (1)

Countries

Mexico (1)  ·  United States (1)